Unknown

Dataset Information

Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.


ABSTRACT: The field of pharmacogenomics was initiated in the 1950s and began to thrive after the completion of the human genome project 10 years ago. Thus far, more than 100 drug labels and clinical guidelines referring to pharmacogenomic biomarkers have been published, and several key pharmacogenomic markers for either drug safety or efficacy have been identified and subsequently adopted in clinical practice as pre-treatment genetic tests. However, a tremendous variation of genetic backgrounds exists between different ethnic groups. The application of pharmacogenomics in the Chinese population is still a long way off, since the published guidelines issued by the organizations such as US Food and Drug Administration require further confirmation in the Chinese population. This review highlights impor

SUBMITTER: Shu WY 

PROVIDER: S-EPMC4422945 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature